Orchestra BioMed Holdings Inc

Research Orchestra BioMed Holdings Inc (OBIO) on Bullrun: market cap USD 284.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerOBIO
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 284.43M
• Financial periodFY2025
• RevenueUSD 33.48M
• Revenue growth1169.2%
• Net income-USD 52.70M
• Free cash flow-USD 49.45M
• Gross margin99.4%

Valuation Snapshot

latest market cap is USD 284.43M.

About Orchestra BioMed Holdings Inc

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease.

Frequently asked questions

What is Orchestra BioMed Holdings Inc's market cap?

Orchestra BioMed Holdings Inc's market capitalization is USD 284.43M.

What does Orchestra BioMed Holdings Inc do?

Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure;